Baroda BNP Paribas
Nifty Midcap 150 Index Fund

(An open-ended scheme replicating / tracking
the Nifty Midcap 150 Total Returns Index)
Baroda BNP Paribas
Nifty Midcap 150 Index Fund

(An open-ended scheme replicating / tracking
the Nifty Midcap 150 Total Returns Index)
February 2025

February 2025


Investment Objective

The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the Nifty Midcap 150 Total Returns Index before expenses, subject to tracking errors, fees, and expenses. However, there is no assurance that the objective of the Scheme will be realized, and the Scheme does not assure or guarantee any returns.

NAV Details ( As on February 28, 2025 )

Regular Plan - Growth Option : ₹ 8.5388
Direct Plan - Growth Option : ₹ 8.5580

Benchmark Index (Tier 1)

Nifty Midcap 150 Total Returns Index

Date of Allotment

November 4, 2024

Fund Manager
Fund Manager Managing fund since Experience
Mr. Neeraj Saxena 4-Nov-24 20 years
Load Structure


Exit Load • 0.2%- If redeemed on or before 7 days from the date of allotment • Nil- If redeemed after 7 days from the date of allotment

For detailed load structure please refer Scheme Information Document of the scheme.


Lumpsum details

Minimum Amount: Lumpsum investment:
₹ 1,000 and in multiples of ₹ 1 thereafter.
Minimum Additional Application Amount:
₹ 1,000 and in multiples of ₹ 1 thereafter.

Monthly AAUM## As on February 28, 2025 : ₹ 7.84 Crores
AUM## As on February 28, 2025 : ₹ 7.43 Crores

## including inter-scheme Investments, if any, by other schemes of BNP Paribas Mutual Fund, as may be applicable

EQUITY HOLDINGS % of Net Assets
Banks 4.87%
The Federal Bank Limited 1.47%
IDFC First Bank Limited 1.24%
Yes Bank Limited 1.10%
AU Small Finance Bank Limited 1.06%
IT - Software 4.62%
Persistent Systems Limited 2.00%
Coforge Limited 1.71%
Mphasis Limited 0.91%
Pharmaceuticals & Biotechnology 4.22%
Lupin Limited 1.54%
Aurobindo Pharma Limited 1.02%
Alkem Laboratories Limited 0.84%
Mankind Pharma Limited 0.82%
Industrial Products 3.70%
Cummins India Limited 1.27%
APL Apollo Tubes Limited 0.88%
Polycab India Limited 0.80%
Supreme Industries Limited 0.75%
Capital Markets 3.61%
BSE Limited 2.35%
HDFC Asset Management Company Limited 1.26%
Healthcare Services 3.58%
Max Healthcare Institute Limited 2.49%
Fortis Healthcare Limited 1.09%
Electrical Equipment 3.33%
Suzlon Energy Limited 2.07%
CG Power and Industrial Solutions Limited 1.26%
Leisure Services 3.01%
The Indian Hotels Company Limited 2.15%
Jubilant Foodworks Limited 0.86%
Consumer Durables 2.81%
Dixon Technologies (India) Limited 1.80%
Voltas Limited 1.01%
Finance 2.73%
Sundaram Finance Limited 1.07%
SBI Cards and Payment Services Limited 0.86%
Muthoot Finance Limited 0.80%
Auto Components 2.58%
Bharat Forge Limited 0.91%
Tube Investments of India Limited 0.91%
Sona BLW Precision Forgings Limited 0.76%
Financial Technology (Fintech) 2.49%
PB Fintech Limited 1.66%
One 97 Communications Limited 0.83%
Fertilizers & Agrochemicals 1.98%
UPL Limited 1.16%
PI Industries Limited 0.82%
Realty 1.94%
Godrej Properties Limited 0.99%
The Phoenix Mills Limited 0.95%
Telecom - Services 1.41%
Indus Towers Limited 1.41%
Chemicals & Petrochemicals 1.39%
SRF Limited 1.39%
Personal Products 1.11%
Colgate Palmolive (India) Limited 1.11%
Agricultural Food & other Products 1.10%
Marico Limited 1.10%
Agricultural, Commercial & Construction Vehicles 1.07%
Ashok Leyland Limited 1.07%
Petroleum Products 0.99%
Hindustan Petroleum Corporation Limited 0.99%
Insurance 0.89%
Max Financial Services Limited 0.89%
Textiles & Apparels 0.87%
Page Industries Limited 0.87%
Transport Infrastructure 0.84%
GMR Airports Limited 0.84%
Power 0.84%
Torrent Power Limited 0.84%
Gas 0.75%
Petronet LNG Limited 0.75%
Minerals & Mining 0.75%
NMDC Limited 0.75%
LESS THAN 0.75% EXPOSURE 42.02%
TOTAL EQUITY HOLDING 99.43%
FIXED INCOME HOLDINGS Rating of Net Assets
TREPS, Cash & Other Net Current Assets 0.57%
GRAND TOTAL 100.00%

Investment in Top 10 scrips constitutes 19.27% of the portfolio


Management Group % of AUM
TATA GROUP 5.16
Public Sector Unit 3.55
PRIVATE (INDIAN) 2.66
Abhay Soi Group 2.49
BSE Group 2.35
Suzlon Group 2.07
Persistent Systems Limited 2.00
Grand Total 20.28


TER - Regular Plan (%) 1.09%
TER - Direct Plan (%) 0.39%
Portfolio Turnover Ratio 0.37
Tracking Error -
Regular 0.24%
Direct 0.24%

* The information contained in this report has been obtained from sources considered to be authentic and reliable. The quantitative data does not purport to be an offer for purchase and sale of mutual fund units.

This product is suitable for investors who are seeking*:

➤ Long term capital growth
➤ Investments in equity and equity related securities replicating the composition of the Nifty Midcap 150 Index with the aim to achieve returns of the stated index, subject to tracking error

*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.

Scheme Riskometer^^
Investors understand that their
principal will be at Very High risk


Benchmark (Tier 1) Riskometer^
Benchmark riskometer is at Very High risk


^^Riskometer For Scheme: basis it’s portfolio, ^Riskometer For Benchmark (Nifty 200 Momentum 30 TRI): basis it’s constituents; as on February 28, 2025

NSE Indices Limited - The Products offered by “Baroda BNP Paribas Mutual Fund/ Baroda BNP Paribas Asset Management India Pvt. Ltd” or its affiliates is not sponsored, endorsed, sold or promoted by NSE Indices Limited (NSE Indices) and its affiliates. NSE Indices and its affiliates do not make any representation or warranty, express or implied (including warranties of merchantability or fitness for particular purpose or use) to the owners of these Products or any member of the public regarding the advisability of investing in securities generally or in the Products linked to their underlying indices to track general stock market performance in India. Please read the full Disclaimers in relation to the underlying indices in the respective Scheme Information Document.


Mutual Fund investments are subject to market risks, read all scheme related documents carefully.